Fig. 1From: Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonatesTrial profile. RA: rheumatoid arthritis; Naive group: treatment-naïve group; Switch group: transitioning from bisphosphonate group; BPs: bisphosphonatesBack to article page